AKT1 and cancer: Overactivation of the RAF/MEK/ERK and phosphatidylinositol‐3‐kinase (PI3K)/protein kinase B (AKT)/mechanistic target of rapamycin (mTOR) pathways enhances growth, survival, and metabolism of cancer cells.